Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NovaBay Pharmaceuticals Inc (NYSE American:NBY)

3.35
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
2.25
Today|||52-Week Range
5.00
+1.52%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues3.5M1.1M4.4M11.9M
 
 
 
 
 
Cost of Goods Sold162.0K254.0K1.1M2.4M
 
 
 
 
 
Depreciation And Amortization314.0K232.0K164.0K114.0K
 
 
 
 
 
 
Operating ExpensesGross Income3.0M568.0K3.1M9.4M
 
 
 
 
 
General Expenses18.5M17.4M24.1M20.6M
 
 
 
 
 
Research And Development12.5M9.5M6.0M1.6M
 
 
 
 
 
Total Operating Expenses19.0M17.9M25.4M23.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-15.5M-16.9M-21.0M-11.1M
 
 
 
 
 
Extraordinary Credit--1.7M2.1M0.00
 
 
 
Extraordinary Charge-555.0K--0.00-2.2M
 
 
 
Other Expenses1.0K22.0K-96.0K164.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-16.0M-15.2M-19.0M-13.1M
 
 
 
 
 
Income Taxes-2.0K-2.0K-12.0K-2.0K
 
 
 
 
 
Net Income-16.0M-15.2M-19.0M-13.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.5M2.0M2.8M9.4M
 
 
 
 
 
Shares To Calculate EPS Diluted1.5M2.0M2.8M9.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$10.50-$7.75-$6.82-$1.40
 
 
 
 
 
EPS Diluted-$10.50-$7.75-$6.82-$1.40